PLXNA3 and major depressive disorder: Glucocorticoid levels fluctuate with menstrual cycles, which might lead to glucocorticoid receptor resistance and sex hormone secretion, and therefore was suggested to be associated with the pathogenesis of female patients with MDD (Zhu et al., 2021).